Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 376, pseudogene (RNU6-376P) is a member of the pseudogene family associated with the U6 small nuclear RNA, which is a highly conserved component of the spliceosome essential for mRNA splicing in eukaryotes[5][1][3]. Unlike the functional U6 small nuclear RNA gene, RNU6-376P is a pseudogene and is not believed to produce a functional RNA product or encode any protein[7]. In general, U6 pseudogenes contain sequences similar to the functional U6 snRNA, but often include mutations, truncations, or duplications that render them non-functional as spliceosomal components[7]. Although most U6 pseudogenes are considered molecular fossils without known physiological roles, emerging evidence suggests some pseudogenes can regulate gene expression by acting as decoys or competing endogenous RNAs that modulate the availability of microRNAs or generate small regulatory RNAs in certain contexts[4][6]. No evidence indicates RNU6-376P acts as a bona fide therapeutic target, nor is it established as a disease biomarker, nor does it interact with known drugs currently. Key points: - **RNU6-376P** is a **pseudogene** of the U6 snRNA gene. - It does **not function as a receptor, enzyme, transporter, or drug target**. - It is classified as **non-coding RNA/pseudogene**, not as a therapeutic or biological target. - Some pseudogenes can influence gene regulation, but there is no specific evidence for such a function for RNU6-376P.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 376, pseudogene (RNU6-376P).